{
    "clinical_study": {
        "@rank": "62092", 
        "arm_group": {
            "arm_group_label": "Qing'E pill", 
            "arm_group_type": "Experimental", 
            "description": "Administered twice a day, and each 9 g"
        }, 
        "brief_summary": {
            "textblock": "This study will investigate the pharmacokinetics of single and multiple doses of Qing'E\n      pills in Chinese menopause volunteers. The main components of Qing'E pill into the blood\n      such as psoralen and Isopsoralen will be detected."
        }, 
        "brief_title": "Pharmacokinetics Study of Qing'E Pill", 
        "condition": "Menopause", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Women age between 40 to 60 Years, Suffering from irregular menstrual cycle or\n             amenorrhea of 3-11 months.\n\n          2. Moderate to severe hot flashes (associated with sweating)\u22655 times /24 hours.\n\n          3. The score of Kupperman index is not less than 15.\n\n          4. Patients unused estrogen tablets or progesterone injection in 6 months.\n\n          5. Patients must discontinue other therapies in the treatment of menopausal syndrome for\n             more than 3 months.\n\n          6. Get subjects informed consent process should comply with GCP requirements.\n\n        Exclusion Criteria:\n\n          1. There is no clinical significance abnormal in physical and laboratory examination.\n\n          2. Bilateral oophorectomy, endometrial lesions, uterine polyps, abnormal vaginal\n             bleeding, severe breast hyperplasia, with family history of breast cancer.\n\n          3. Patients with hypertension, primary hypotension and chronic anemia (Hb \u2264 90 g/L).\n\n          4. Patients with hyperthyroidism, coronary atheroma, diabetes, obesity (body mass index\n             of more than 30 kg/m2), migraine, malignant tumors, thromboembolic disease,\n             gastrointestinal diseases affect absorption or autoimmune diseases.\n\n          5. Patients with diseases of the cardiovascular, cerebrovascular, liver, kidney and\n             hematopoietic system, or mentally ill.\n\n          6. People with allergies.\n\n          7. People taking other drugs within 14 days before the trail.\n\n          8. Patients are participating in other clinical trials within 3 months.\n\n          9. Pregnant Women.\n\n         10. Alcoholics or smokers (past or smoking)."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01931436", 
            "org_study_id": "QE-2458-2"
        }, 
        "intervention": {
            "arm_group_label": "Qing'E pill", 
            "description": "Qing'E pill is composed of eucommia, psoralen, walnuts and garlic.", 
            "intervention_name": "Qing'E pill", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Contraceptives, Oral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Menopause, pharmacokinetic", 
        "lastchanged_date": "August 26, 2013", 
        "location": {
            "contact": {
                "email": "yangjie@wuxiph.com", 
                "last_name": "Yang Jie, MD", 
                "phone": "+86-0510-85350351"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "210038"
                }, 
                "name": "Shanghai University of Traditional Chinese Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Single-site, Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics of the Main Components of Qing'E Pill (a Chinese Medicine Formula) Into the Blood in Chinese Menopausal Women", 
        "overall_contact": {
            "email": "zheng.zqs@gmail.com", 
            "last_name": "Zheng Qingshan, MD", 
            "phone": "+86-021-51322556"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To detect the main components of Qing'E pill into the blood such as psoralen and Isopsoralen.", 
            "measure": "Pharmacokinetic parameters of the main components of Qing'E pill (Maximum plasma concentration (Cmax), Area under the plasma concentration curve (AUClast and AUC))", 
            "safety_issue": "No", 
            "time_frame": "Up to 48 hours postdose for each period"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01931436"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Shanghai University of Traditional Chinese Medicine", 
        "sponsors": {
            "collaborator": {
                "agency": "Wuxi People\u2019s Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Shanghai University of Traditional Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}